Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Cook

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
Lancet (London, England)|September 29, 2009
Challenges in evaluating surgical innovationPatrick L Ergina, Jonathan A Cook, Jane M Blazeby, et al.
The Lancet. Gastroenterology & Hepatology|September 1, 2020
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry studyGwilym J Webb, Thomas Marjot, Jonathan A Cook, et al.
Lancet (London, England)|August 21, 2022
Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trialDavid J Beard, Loretta Davies, Jonathan A Cook, et al.
Health Technology Assessment (Winchester, England)|June 28, 2024
Comparison of surgical or non-surgical management for non-acute anterior cruciate ligament injury: the ACL SNNAP RCTDavid J Beard, Loretta Davies, Jonathan A Cook, et al.
The Lancet. Rheumatology|January 24, 2024
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Nicholas Peckham, Corinna Pade, et al.
The Lancet. Haematology|April 2, 2025
A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trialJonathan A Cook, Piers E M Patten, Nicholas Peckham, et al.
Health Technology Assessment (Winchester, England)|September 10, 2021
Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshopDavid J Beard, Marion K Campbell, Jane M Blazeby, et al.
Journal of Hepatology|October 9, 2020
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry studyThomas Marjot, Andrew M Moon, Jonathan A Cook, et al.
Lancet (London, England)|March 9, 2020
Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)David J Beard, Marion K Campbell, Jane M Blazeby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Risk Stratification in Older Intensively Treated Patients With AMLJurjen Versluis, Marlen Metzner, Ariel Wang, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
Lancet (London, England)|September 29, 2009
Challenges in evaluating surgical innovationPatrick L Ergina, Jonathan A Cook, Jane M Blazeby, et al.
The Lancet. Gastroenterology & Hepatology|September 1, 2020
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry studyGwilym J Webb, Thomas Marjot, Jonathan A Cook, et al.
Lancet (London, England)|August 21, 2022
Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trialDavid J Beard, Loretta Davies, Jonathan A Cook, et al.
Health Technology Assessment (Winchester, England)|June 28, 2024
Comparison of surgical or non-surgical management for non-acute anterior cruciate ligament injury: the ACL SNNAP RCTDavid J Beard, Loretta Davies, Jonathan A Cook, et al.
The Lancet. Rheumatology|January 24, 2024
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Nicholas Peckham, Corinna Pade, et al.
The Lancet. Haematology|April 2, 2025
A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trialJonathan A Cook, Piers E M Patten, Nicholas Peckham, et al.
Health Technology Assessment (Winchester, England)|September 10, 2021
Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshopDavid J Beard, Marion K Campbell, Jane M Blazeby, et al.
Journal of Hepatology|October 9, 2020
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry studyThomas Marjot, Andrew M Moon, Jonathan A Cook, et al.
Lancet (London, England)|March 9, 2020
Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)David J Beard, Marion K Campbell, Jane M Blazeby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2024
Risk Stratification in Older Intensively Treated Patients With AMLJurjen Versluis, Marlen Metzner, Ariel Wang, et al.
Pageof 14